The October 2018 digital edition includes MM&M’s annual Career and Salary Survey, pipeline watch, and the pro ad report for the first half of 2018.
Takeda-Shire merger receives Japanese approval; Publicis Groupe said to be divesting Publicis Health Services; Anthem and HealthCore launch type 2 diabetes study
Facebook Health’s Danielle Salowski and Merck’s Nancy Nolan shared best practices for Instagram at Digital Pharma East in Philadelphia.
PhRMA pushed back on the HHS plan for disclosing drug prices in ads, putting itself in Trump’s Twitter crosshairs, but experts say flaws in the plan could impede its rollout anyway.
Merck hires Nike exec as chief information, digital officer; Minnesota sues three insulin makers over pricing; UnitedHealth Q3 beats expectations.
WPP will create integrated campaigns and content encompassing advertising, digital, shopper activation and PR.
Agencies that view philanthropy merely as pro-bono work shortchange their people and are missing a chance to bring private-sector creativity to public health needs.
Immunotherapy’s modern era has been characterized by a tremendous amount of scientific and regulatory activity. Trace the road to the Nobel.
The holding company beat analysts’ estimates by reporting net income for its overall business was up more than 13% in the period.
Drugmakers are among the healthcare organizations working to make external collaboration more common.